Trade ALX Oncology Holdings Inc. - ALXO CFD
Add to favourite- Summary
- Historical Data
| Spread | 0.05 | ||||||||
|
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.024124% | ||||||||
|
Short position overnight fee
Short position overnight funding adjustment
Go to platform | 0.001901% | ||||||||
| Overnight fee time | 22:00 (UTC) | ||||||||
| Min traded quantity | 1 | ||||||||
| Currency | USD | ||||||||
| Margin | 50.00% | ||||||||
| Stock exchange | United States of America | ||||||||
| Commission on trade | 0% |
| Prev. Close | 1.2 |
| Open | 1.21 |
| 1-Year Change | -87.63% |
| Day's Range | 1.19 - 1.3 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Nov 20, 2024 | 1.20 | 0.01 | 0.84% | 1.19 | 1.22 | 1.19 |
| Nov 19, 2024 | 1.20 | 0.01 | 0.84% | 1.19 | 1.24 | 1.17 |
| Nov 18, 2024 | 1.20 | -0.05 | -4.00% | 1.25 | 1.28 | 1.19 |
| Nov 15, 2024 | 1.27 | -0.06 | -4.51% | 1.33 | 1.33 | 1.22 |
| Nov 14, 2024 | 1.32 | 0.02 | 1.54% | 1.30 | 1.35 | 1.30 |
| Nov 13, 2024 | 1.32 | -0.02 | -1.49% | 1.34 | 1.38 | 1.27 |
| Nov 12, 2024 | 1.33 | -0.14 | -9.52% | 1.47 | 1.47 | 1.32 |
| Nov 11, 2024 | 1.46 | -0.01 | -0.68% | 1.47 | 1.55 | 1.45 |
| Nov 8, 2024 | 1.44 | -0.08 | -5.26% | 1.52 | 1.61 | 1.43 |
| Nov 7, 2024 | 1.49 | 0.00 | 0.00% | 1.49 | 1.53 | 1.43 |
| Nov 6, 2024 | 1.50 | -0.03 | -1.96% | 1.53 | 1.54 | 1.43 |
| Nov 5, 2024 | 1.49 | 0.04 | 2.76% | 1.45 | 1.49 | 1.43 |
| Nov 4, 2024 | 1.47 | 0.05 | 3.52% | 1.42 | 1.54 | 1.42 |
| Nov 1, 2024 | 1.44 | 0.04 | 2.86% | 1.40 | 1.49 | 1.38 |
| Oct 31, 2024 | 1.41 | 0.04 | 2.92% | 1.37 | 1.44 | 1.31 |
| Oct 30, 2024 | 1.35 | -0.04 | -2.88% | 1.39 | 1.41 | 1.34 |
| Oct 29, 2024 | 1.37 | -0.06 | -4.20% | 1.43 | 1.50 | 1.35 |
| Oct 28, 2024 | 1.43 | -0.04 | -2.72% | 1.47 | 1.50 | 1.41 |
| Oct 25, 2024 | 1.45 | -0.01 | -0.68% | 1.46 | 1.49 | 1.44 |
| Oct 24, 2024 | 1.43 | -0.21 | -12.80% | 1.64 | 1.64 | 1.43 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 20
- 100
- 500
- 1000
- 10000
ALX Oncology Holdings Inc. Company profile
About ALX Oncology Holdings Inc
ALX Oncology Holdings Inc. is a clinical-stage immuno-oncology company. The Company is focused on enabling patients to fight cancer by developing therapies that block the cluster of differentiation 47 (CD47) checkpoint pathway and bridge the innate and adaptive immune system. The Company is developing a checkpoint inhibitor designed to have an affinity for CD47 and to avoid the limitations caused by hematologic toxicities inherent in other CD47 blocking approaches. Its lead product candidate, ALX148, is a CD47 blocking therapeutic. ALX148 is a fusion protein that combines a CD47 binding domain with its inactivated fragment crystallizable (Fc) domain. The CD47 binding domain of ALX148 is an affinity enhanced extracellular domain of signal regulatory protein alpha (SIRPa), a protein that is the natural receptor to CD47 found on myeloid cells. Its programs are focused on targeting CD47 across various oncology indications.
Financial summary
BRIEF: For the fiscal year ended 31 December 2021, ALX Oncology Holdings Inc revenues decreased from $1.2M to $0K. Net loss applicable to common stockholders increased 64% to $83.5M. Revenues reflect a decrease in demand for the Company's products and services due to unfavorable market conditions. Higher net loss reflects Reserach and developement increase of 76% to $46.5M (expense).
| Industry: | Bio Therapeutic Drugs |
323 Allerton Avenue
SOUTH SAN FRANCISCO
CALIFORNIA 94080
US
News
Gold price predictions for the next five years: Third party data round up
Explore the future of gold prices and whether the yellow metal will continue its upward trend in the coming years.
15:17, 18 November 2024
Shiba Inu coin price prediction 2030: could Shiba Inu coin reach $1? Third party price target
Can Shiba Inu reinvent itself to become a worthy long-term investment?
08:36, 15 November 2024
Trump trades charge as Bitcoin hits $US80,000
Bitcoin hits $80,000 amid expectations of fiscal stimulus, lower regulatory risks, and resilient US economy.
10:48, 13 November 2024
Australian jobs data expected to point to solid labour market conditions
Australian labour market and wage data to reveal job growth resilience, shaping RBA rate cut expectations and impacting AUD amidst global economic shifts.
10:16, 13 November 2024
FOMC cuts interest rates as expected and sticks to its line on future policy
The FOMC cut interest rates by 25 basis points at its November meeting, aligning with expectations. Wall Street hit record highs following the decision, with tech stocks leading the rally. Markets are pricing in a probable December cut amid resilient economic indicators.
13:33, 8 November 2024
FOMC and BOE preview: further rate cuts expected
Both the Federal Reserve and the Bank of England are expected to cut rates further when they meet later this week.
14:14, 5 November 2024
RBA meeting preview: No change to policy expected as inflation fight continues
The Reserve Bank of Australia is expected to keep its cash rate on hold at 4.35% when it announces its policy decision at 2.30PM on the 5th of November, 2024. Despite ongoing evidence of soft demand, upside risks to inflation are likely to remain the central bank’s primary concern.
13:35, 4 November 2024People also watch
Still looking for a broker you can trust?
Join the 660,000+ traders worldwide that chose to trade with Capital.com